USNA - USANA Health Sciences, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 51.57B
Enterprise value 31.33B
Trailing P/E 15.65
Forward P/E 115.81
PEG Ratio (5 yr expected) 11.82
Price/sales (ttm)1.40
Price/book (mrq)4.22
Enterprise value/revenue 31.18
Enterprise value/EBITDA 67.57

Trading information

Stock price history

Beta (3Y monthly) 0.46
52-week change 3-32.80%
S&P500 52-week change 38.02%
52-week high 3125.61
52-week low 358.30
50-day moving average 369.43
200-day moving average 372.76

Share statistics

Avg vol (3-month) 3210.56k
Avg vol (10-day) 3165.38k
Shares outstanding 522.26M
Float 10.57M
% held by insiders 142.41%
% held by institutions 153.83%
Shares short (30 Sep 2019) 41.56M
Short ratio (30 Sep 2019) 49.34
Short % of float (30 Sep 2019) 411.63%
Short % of shares outstanding (30 Sep 2019) 47.00%
Shares short (prior month 30 Aug 2019) 41.62M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor (new per old) 21/2
Last split date 323 Nov 2016

Financial highlights

Fiscal year

Fiscal year ends 29 Dec 2018
Most-recent quarter (mrq)29 Jun 2019

Profitability

Profit margin 9.68%
Operating margin (ttm)14.19%

Management effectiveness

Return on assets (ttm)18.01%
Return on equity (ttm)26.78%

Income statement

Revenue (ttm)1.12B
Revenue per share (ttm)47.42
Quarterly revenue growth (yoy)-15.10%
Gross profit (ttm)988.54M
EBITDA 175.4M
Net income avi to common (ttm)108.92M
Diluted EPS (ttm)4.50
Quarterly earnings growth (yoy)-37.00%

Balance sheet

Total cash (mrq)234.35M
Total cash per share (mrq)10.53
Total debt (mrq)19.43M
Total debt/equity (mrq)5.06
Current ratio (mrq)2.71
Book value per share (mrq)16.72

Cash flow statement

Operating cash flow (ttm)115.61M
Levered free cash flow (ttm)100.77M